AI assistant
Sending…
Navamedic — Director's Dealing 2021
Mar 26, 2021
3668_rns_2021-03-26_4ebad55d-5f7b-4217-9893-01413f488aec.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Notification of transactions by Primary Insiders and Close Associates
| 1 | Details of the Primary Insider/Close Associate | |||
|---|---|---|---|---|
| a) | Name | Ingerø Reiten Investment Company AS | ||
| 2 | Reason for the notification | |||
| a) | Position/status | The notification concerns a legal person closely associated with a Primary Insider: Narve Reiten, Board Member of Navamedic ASA. |
||
| b) | Initial notification/ Amendment |
Initial notification. | ||
| 3 | Details of Navamedic ASA, emission allowance market participant, auction platform, auctioneer or | |||
| auction monitor | ||||
| a) | Name | Navamedic ASA | ||
| b) | LEI | 529900LKVQOR2SRUJU71 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Nature of the instrument: Shares Instrument identification code (ISIN): NO0010205966 |
||
| b) | Nature of the transaction | Pedging of shares. Transaction is not linked to the exercise of a share option programme. |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 3 563 042 | |||
| Transaction currency in NOK. | ||||
| d) | Aggregated information | Price: 0 NOK | ||
| — Aggregated volume |
Volume: 3 563 042 shares | |||
| — Price |
||||
| e) | Date of the transaction | 2021-03-26 | ||
| f) | Place of the transaction | XOSL – Oslo Børs |
More from Navamedic
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 20
Major Shareholding Notification
2026
May 20
Major Shareholding Notification
2026
May 19
Director's Dealing
2026
May 18
Director's Dealing
2026
May 18
Major Shareholding Notification
2026
May 15
Major Shareholding Notification
2026
May 15
Investor Presentation
2026
Apr 23
Investor Presentation
2026
Apr 23